Contribution of hepatic stellate cells and matrix metalloproteinase 9 in acute liver failure

Liver International

Volumn 28, Issue 7, 2008, Pages 959-971

  Yan, Chunli ^a   Zhou, Ling ^a   Han, Yuan Ping ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

Caspase; Extracellular matrix; Fulminant hepatitis; Hepatic stellate cells; Interleukin 1; Matrix metalloproteinases

Indexed keywords

CARBON TETRACHLORIDE; CASPASE 3; COLLAGEN TYPE 4; GALACTOSAMINE; GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; COLLAGEN DEGRADATION; CONTROLLED STUDY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LETHALITY; LIVER CELL; LIVER DYSFUNCTION; LIVER FAILURE; LIVER INJURY; LIVER PARENCHYMA; LIVER SINUSOID; MICROENVIRONMENT; MOUSE; NONHUMAN; STELLATE CELL; THREE DIMENSIONAL IMAGING; TIME;

ANIMALS; CARBON TETRACHLORIDE; CASPASE 3; COLLAGEN TYPE IV; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; GALACTOSAMINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATIC STELLATE CELLS; HEPATITIS, TOXIC; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; LIVER; LIVER FAILURE, ACUTE; LONGEVITY; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; NECROSIS; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 47949111247     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01775.x     Document Type: Article

References (45)

1. O'Grady JG. Acute liver failure. Postgrad Med J 2005; 81: 148-54.
2. Bernal W, Wendon J. Acute liver failure; clinical features and management. Eur J Gastroenterol Hepatol 1999; 11: 977-84.
3. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000; 32: 734-9.
4. Ramadori G, Armbrust T. Cytokines in the liver. Eur J Gastroenterol Hepatol 2001; 13: 777-84.
5. Blazka ME, Wilmer JL, Holladay SD, Wilson RE, Luster MI. Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 1995; 133: 43-52.
6. Liu ZX, Govindarajan S, Kaplowitz N. Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 2004; 127: 1760-74.
7. Bird GL, Sheron N, Goka AK, Alexander GJ, Williams RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990; 112: 917-20.
8. Muto Y, Nouri-Aria KT, Meager A, Alexander GJ, Eddleston AL, Williams R. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 1988; 2: 72-4.
9. Sekiyama KD, Yoshiba M, Thomson AW. Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol 1994; 98: 71-7.
10. Parks WC. Matrix metalloproteinases in repair. Wound Repair Regen 1999; 7: 423-32.
11. Han YP. Matrix metalloproteinases, the pros and cons, in liver fibrosis. J Gastroenterol Hepatol 2006; 21 (Suppl. 3): S88-91.
12. Han YP, Nien YD, Garner WL. Tumor necrosis factor-alpha-induced proteolytic activation of pro-matrix metalloproteinase-9 by human skin is controlled by down-regulating tissue inhibitor of metalloproteinase-1 and mediated by tissue-associated chymotrypsin-like proteinase. J Biol Chem 2002; 277: 27319-27.
13. Han YP, Downey S, Garner WL. Interleukin-1alpha-induced proteolytic activation of metalloproteinase-9 by human skin. Surgery 2005; 138: 932-9.
14. Wielockx B, Lannoy K, Shapiro SD, et al. Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy. Nat Med 2001; 7: 1202-8.
15. Van Lint P, Wielockx B, Puimege L, Noel A, Lopez-Otin C, Libert C. Resistance of collagenase-2 (matrix metalloproteinase-8)-deficient mice to TNF-induced lethal hepatitis. J Immunol 2005; 175: 7642-9.
16. Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis 2001; 21: 311-35.
17. Han YP, Zhou L, Wang J, et al. Essential role of matrix metalloproteinases in interleukin-1-induced myofibroblastic activation of hepatic stellate cell in collagen. J Biol Chem 2004; 279: 4820-8.
18. Han YP, Nien YD, Garner WL. Recombinant human platelet-derived growth factor and transforming growth factor-beta mediated contraction of human dermal fibroblast populated lattices is inhibited by Rho/GTPase inhibitor but does not require phosphatidylinositol-3′ kinase. Wound Repair Regen 2002; 10: 169-76.
19. Han YP, Yan C, Zhou L, Qin L, Tsukamoto H. A matrix metalloproteinase-9 activation cascade by hepatic stellate cells in trans-differentiation in the three-dimensional extracellular matrix. J Biol Chem 2007; 282: 12928-39.
20. Wake K. Cell-cell organization and functions of 'sinusoids' in liver microcirculation system. J Electron Microsc 1999; 48: 89-98.
21. Rechnagel RO, Glende EA, Jr. Carbon tetrachloride hepatotoxicity: An example of lethal cleavage. CRC Crit Rev Toxicol 1973; 2: 263-97.
22. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115: 209-18.
23. Sun MA, Wang BE, Annoni G, Degli Esposti S, Biempica L, Zern MA. Two rat models of hepatic fibrosis. A morphologic and molecular comparison. Lab Invest 1990; 63: 467-75.
24. Eguchi H, McCuskey PA, McCuskey RS. Kupffer cell activity and hepatic microvascular events after acute ethanol ingestion in mice. Hepatology 1991; 13: 751-7.
25. Schuppan D. Structure of the extracellular matrix in normal and fibrotic liver: Collagens and glycoproteins. Semin Liver Dis 1990; 10: 1-10.
26. Rothe J, Lesslauer W, Lotscher H, et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993; 364: 798-802.
27. Nowak M, Gaines GC, Rosenberg J, et al. LPS-induced liver injury in d-galactosamine-sensitized mice requires secreted TNF-alpha and the TNF-p55 receptor. Am J Physiol Regul Integr Comp Physiol 2000; 278: R1202-9.
28. Josephs MD, Bahjat FR, Fukuzuka K, et al. Lipopolysaccharide and d -galactosamine-induced hepatic injury is mediated by TNF-alpha and not by Fas ligand. Am J Physiol Regul Integr Comp Physiol 2000; 278: R1196-201.
29. Van Molle W, Denecker G, Rodriguez I, Brouckaert P, Vandenabeele P, Libert C. Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins. J Immunol 1999; 163: 5235-41.
30. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 2002; 3: 221-7.
31. Sakurai T, Maeda S, Chang L, Karin M. Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained C-Jun N-terminal kinase 1 activation. Proc Natl Acad Sci USA 2006; 103: 10544-51.
32. Keppler D, Lesch R, Reutter W, Decker K. Experimental hepatitis induced by d-galactosamine. Exp Mol Pathol 1968; 9: 279-90.
33. Schlayer HJ, Laaff H, Peters T, et al. Involvement of tumor necrosis factor in endotoxin-triggered neutrophil adherence to sinusoidal endothelial cells of mouse liver and its modulation in acute phase. J Hepatol 1988; 7: 239-49.
34. Dinarello CA. Interleukin-1. Cytokine Growth Factor Rev 1997; 8: 253-65.
35. Nagakawa J, Hishinuma I, Hirota K, et al. Interleukin-1 alpha enhances hepatotoxicity of tumor necrosis factor-alpha in galactosamine-sensitized mice. Immunopharmacol Immunotoxicol 1991; 13: 485-98.
36. van Molle W, Brouckaert P, Libert C. Caspase-1 is not involved in experimental hepatitis in mouse. FEBS Lett 1999; 445: 115-8.
37. Solorzano CC, Ksontini R, Pruitt JH, et al. A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor alpha (TNF alpha) and abrogates endotoxin-induced lethality. Shock 1997; 7: 427-31.
38. Winwood PJ, Schuppan D, Iredale JP, Kawser CA, Docherty AJ, Arthur MJ. Kupffer cell-derived 95-kd type IV collagenase/gelatinase B: characterization and expression in cultured cells. Hepatology 1995; 22: 304-15.
39. Guicciardi ME, Gores GJ. Apoptosis: A mechanism of acute and chronic liver injury. Gut 2005; 54: 1024-33.
40. Lee SR, Lo EH. Induction of caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after hypoxia-reoxygenation. J Cereb Blood Flow Metab 2004; 24: 720-7.
41. Ishizuya-Oka A, Li Q, Amano T, Damjanovski S, Ueda S, Shi YB. Requirement for matrix metalloproteinase stromelysin-3 in cell migration and apoptosis during tissue remodeling in Xenopus laevis. J Cell Biol 2000; 150: 1177-88.
42. Murphy FR, Issa R, Zhou X, et al. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem 2002; 277: 11069-76.
43. Leu JI, Crissey MA, Taub R. Massive hepatic apoptosis associated with TGF-beta 1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice. J Clin Invest 2003; 111: 129-39.
44. Araya R, Uehara T, Nomura Y. Hypoxia induces apoptosis in human neuroblastoma SK-N-MC cells by caspase activation accompanying cytochrome c release from mitochondria. FEBS Lett 1998; 439: 168-72.
45. Mishra OP, Randis T, Ashraf QM, Delivoria-Papadopoulos M. Hypoxia-induced Bax and Bcl-2 protein expression, caspase-9 activation, DNA fragmentation, and lipid peroxidation in mitochondria of the cerebral cortex of newborn piglets: The role of nitric oxide. Neuroscience 2006; 141: 1339-49.